COMT and ANKK1 gene-gene interaction modulates contextual updating of mental representations

NeuroImage

Volumn 56, Issue 3, 2011, Pages 1641-1647

  Garcia Garcia, M ^a   Barcelo F ^b   Clemente, I C ^a   Escera, C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

COMT; Contextual update; D2 receptors; Dopamine; Novelty P3

Indexed keywords

ANKYRIN REPEAT AND PROTEIN KINASE DOMAIN CONTAINING 1; CATECHOL METHYLTRANSFERASE; DOPAMINE; GENE PRODUCT; UNCLASSIFIED DRUG;

ADULT; ANKK1 GENE; ARTICLE; ASSOCIATION; COMT GENE; CONTROLLED STUDY; EPISTASIS; EVENT RELATED POTENTIAL; FEMALE; GENE; GENE EXPRESSION; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; MALE; MENTAL FUNCTION; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR DENSITY; SENSORY ANALYSIS; STRIATE CORTEX; TASK PERFORMANCE; VOLUNTEER;

ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; COGNITION; CUES; DATA INTERPRETATION, STATISTICAL; DNA; DOPAMINE; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; GENOTYPE; HUMANS; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PROTEIN-SERINE-THREONINE KINASES; PSYCHOMOTOR PERFORMANCE; RECEPTORS, DOPAMINE D2; SET (PSYCHOLOGY); YOUNG ADULT;

EID: 79955481491     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.02.053     Document Type: Article

References (70)

1. Akil M., Kolachana B.S., Rothmond D.A., Hyde T.M., Weinberger D.R., Kleinman J.E. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J. Neurosci. Off. J. Soc. Neurosci. 2003, 23(6):2008-2013.
2. Arnsten A.F.T. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn. Sci. 1998, 2:436-447.
3. Barcelo F. The Madrid card sorting test (MCST): a task switching paradigm to study executive attention with event-related potentials. Brain Res. Brain Res. Protoc. 2003, 11(1):27-37.
4. Barcelo F., Escera C., Corral M.J., Perianez J.A. Task switching and novelty processing activate a common neural network for cognitive control. J. Cogn. Neurosci. 2006, 18(10):1734-1748. 10.1162/jocn.2006.18.10.1734.
5. Barcelo F., Munoz-Cespedes J.M., Pozo M.A., Rubia F.J. Attentional set shifting modulates the target P3b response in the Wisconsin card sorting test. Neuropsychologia 2000, 38(10):1342-1355.
6. Barcelo F., Perianez J.A., Knight R.T. Think differently: a brain orienting response to task novelty. NeuroReport 2002, 13(15):1887-1892.
7. Barcelo F., Perianez J.A., Nyhus E. An information theoretical approach to task-switching: evidence from cognitive brain potentials in humans. Front. Hum. Neurosci. 2007, 1:13. 10.3389/neuro.09.013.2007.
8. Becker J.B., Cha J.H. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav. Brain Res. 1989, 35(2):117-125.
9. Becker J.B., Robinson T.E., Lorenz K.A. Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior. Eur. J. Pharmacol. 1982, 80(1):65-72.
10. Belouchrani A., Abed-Meraim K., Cardoso J.F., Moulines E. A blind source separation technique using second-order statistics. IEEE Trans. Signal Process. 1997, 45(2):434-444.
11. Bilder R.M., Volavka J., Lachman H.M., Grace A.A. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2004, 29(11):1943-1961. 10.1038/sj.npp. 1300542.
12. Brass M., Derrfuss J., Forstmann B., von Cramon D.Y. The role of the inferior frontal junction area in cognitive control. Trends Cogn. Sci. 2005, 9(7):314-316. 10.1016/j.tics.2005.05.001.
13. Bush G., Spencer T.J., Holmes J., Shin L.M., Valera E.M., Seidman L.J., et al. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch. Gen. Psychiatry 2008, 65(1):102-114. 10.1001/archgenpsychiatry.2007.16.
14. Bush G., Valera E.M., Seidman L.J. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol. Psychiatry 2005, 57(11):1273-1284. 10.1016/j.biopsych.2005.01.034.
15. Camps M., Cortes R., Gueye B., Probst A., Palacios J.M. Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience 1989, 28(2):275-290.
16. Cools R. Role of dopamine in the motivational and cognitive control of behavior. Neuroscientist Rev. J. Bringing Neurobiol. Neurol. Psychiatry 2008, 14(4):381-395. 10.1177/1073858408317009.
17. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb. Cortex (New York, N.Y.: 1991) 2001, 11(12):1136-1143.
18. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. L-dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 2003, 41(11):1431-1441.
19. Cools R., Clark L., Robbins T.W. Differential responses in human striatum and prefrontal cortex to changes in object and rule relevance. J. Neurosci. Off. J. Soc. Neurosci. 2004, 24(5):1129-1135. 10.1523/JNEUROSCI.4312-03.2004.
20. Cools R., Ivry R.B., D'Esposito M. The human striatum is necessary for responding to changes in stimulus relevance. J. Cogn. Neurosci. 2006, 18(12):1973-1983. 10.1162/jocn.2006.18.12.1973.
21. Crofts H.S., Dalley J.W., Collins P., Van Denderen J.C., Everitt B.J., Robbins T.W., et al. Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cereb. Cortex (New York, N.Y.: 1991) 2001, 11(11):1015-1026.
22. Dien J., Spencer K.M., Donchin E. Localization of the event-related potential novelty response as defined by principal components analysis. Brain Res. Cogn. Brain Res. 2003, 17(3):637-650.
23. Dreher J.C., Schmidt P.J., Kohn P., Furman D., Rubinow D., Berman K.F. Menstrual cycle phase modulates reward-related neural function in women. Proc. Natl Acad. Sci. USA 2007, 104(7):2465-2470. 10.1073/pnas.0605569104.
24. Durstewitz D., Seamans J.K. The computational role of dopamine D1 receptors in working memory. Neural Netw. Off. J. Int. Neural Netw. Soc. 2002, 15(4-6):561-572.
25. Durstewitz D., Seamans J.K., Sejnowski T.J. Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J. Neurophysiol. 2000, 83(3):1733-1750.
26. Durston S., Tottenham N.T., Thomas K.M., Davidson M.C., Eigsti I.M., Yang Y., et al. Differential patterns of striatal activation in young children with and without ADHD. Biol. Psychiatry 2003, 53(10):871-878.
27. Escera C., Alho K., Schroger E., Winkler I. Involuntary attention and distractibility as evaluated with event-related brain potentials. Audiol. Neuro-Otol. 2000, 5(3-4):151-166.
28. Escera C., Alho K., Winkler I., Naatanen R. Neural mechanisms of involuntary attention to acoustic novelty and change. J. Cogn. Neurosci. 1998, 10(5):590-604.
29. Escera C., Corral M.J. Role of mismatch negativity and novelty-P3 in involuntary auditory attention. J. Psychophysiol. 2007, 21(3-4):251-264.
30. Escera C., Yago E., Alho K. Electrical responses reveal the temporal dynamics of brain events during involuntary attention switching. Eur. J. Neurosci. 2001, 14(5):877-883.
31. Frank M.J. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated parkinsonism. J. Cogn. Neurosci. 2005, 17(1):51-72. 10.1162/0898929052880093.
32. Bakan D. The test of significance in psychological research. Psychol. Bull. 1966, 66(6):423-437.
33. Friston K.J., et al. Statistical parametric mapping: the analysis of functional brain images 2007, 3-9. Elsevier/Academic Press, Amsterdam; London.
34. Friston K.J., Penny W., Phillips C., Kiebel S., Hinton G., Ashburner J. Classical and Bayesian inference in neuroimaging: theory. Neuroimage 2002, 16(2):465-483.
35. Garcia-Garcia M., Barcelo F., Clemente I.C., Escera C. The role of the dopamine transporter DAT1 genotype on the neural correlates of cognitive flexibility. Eur. J. Neurosci. 2010, 31(4):754-760.
36. Garcia-Garcia M., Clemente I., Dominguez-Borras J., Escera C. Dopamine transporter regulates the enhancement of novelty processing by a negative emotional context. Neuropsychologia 2010, 48(5):1483-1488.
37. Huang M.X., Lee R.R., Miller G.A., Thoma R.J., Hanlon F.M., Paulson K.M., et al. A parietal-frontal network studied by somatosensory oddball MEG responses, and its cross-modal consistency. Neuroimage 2005, 28(1):99-114. 10.1016/j.neuroimage.2005.05.036.
38. Jonsson E.G., Nothen M.M., Grunhage F., Farde L., Nakashima Y., Propping P., et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry 1999, 4(3):290-296.
39. Kaplan F., Oudeyer P.Y. In search of the neural circuits of intrinsic motivation. Front. Neurosci. 2007, 1(1):225-236. 10.3389/neuro.01.1.1.017.2007.
40. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6(3):243-250.
41. Lewis D.A., Melchitzky D.S., Sesack S.R., Whitehead R.E., Auh S., Sampson A. Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J. Comp. Neurol. 2001, 432(1):119-136.
42. Lewis S.J., Dove A., Robbins T.W., Barker R.A., Owen A.M. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J. Neurosci. Off. J. Soc. Neurosci. 2003, 23(15):6351-6356.
43. Makris N., Seidman L.J., Valera E.M., Biederman J., Monuteaux M.C., Kennedy D.N., et al. Anterior cingulate volumetric alterations in treatment-naive adults with ADHD: a pilot study. J. Atten. Disord. 2010, 13(4):407-413. 10.1177/1087054709351671.
44. Mannisto P.T., Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 1999, 51(4):593-628.
45. Mehta M.A., Manes F.F., Magnolfi G., Sahakian B.J., Robbins T.W. Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology 2004, 176(3-4):331-342. 10.1007/s00213-004-1899-2.
46. Mehta M.A., Owen A.M., Sahakian B.J., Mavaddat N., Pickard J.D., Robbins T.W. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J. Neurosci. Off. J. Soc. Neurosci. 2000, 20(6):RC65.
47. Meiran N., Friedman G., Yehene E. Parkinson's disease is associated with goal setting deficits during task switching. Brain Cogn. 2004, 54(3):260-262. 10.1016/j.bandc.2004.02.043.
48. Meyer-Lindenberg A., Miletich R.S., Kohn P.D., Esposito G., Carson R.E., Quarantelli M., et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat. Neurosci. 2002, 5(3):267-271. 10.1038/nn804.
49. Neville M.J., Johnstone E.C., Walton R.T. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum. Mutat. 2004, 23(6):540-545. 10.1002/humu.20039.
50. Nigg J.T., Casey B.J. An integrative theory of attention-deficit/ hyperactivity disorder based on the cognitive and affective neurosciences. Dev. Psychopathol. 2005, 17(3):785-806. 10.1017/S0954579405050376.
51. Perianez J.A., Barcelo F. Updating sensory versus task representations during task-switching: insights from cognitive brain potentials in humans. Neuropsychologia 2009, 47(4):1160-1172.
52. Petersson K.M., Nichols T.E., Poline J.B., Holmes A.P. Statistical limitations in functional neuroimaging II. Signal detection and statistical inference. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1999, 354(1387):1261-1281.
53. Pohjalainen T., Rinne J.O., Nagren K., Lehikoinen P., Anttila K., Syvalahti E.K., et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol. Psychiatry 1998, 3(3):256-260.
54. Reuter M., Peters K., Schroeter K., Koebke W., Lenardon D., Bloch B., et al. The influence of the dopaminergic system on cognitive functioning: a molecular genetic approach. Behav. Brain Res. 2005, 164(1):93-99. 10.1016/j.bbr.2005.06.002.
55. Reuter M., Schmitz A., Corr P., Hennig J. Molecular genetics support gray's personality theory: the interaction of COMT and DRD2 polymorphisms predicts the behavioural approach system. Int. J. Neuropsychopharmacol. / Off. Sci. J. Coll. Int. Neuropsychopharmacologicum (CINP) 2006, 9(2):155-166. 10.1017/S1461145705005419.
56. Ritchie T., Noble E.P. Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem. Res. 2003, 28(1):73-82.
57. Rogers R.D., Monsell S. Costs of a predictable switch between simple cognitive tasks. J. Exp. Psychol. Gen. 1995, 124:207-231.
58. Rubinstein J.S., Meyer D.E., Evans J.E. Executive control of cognitive processes in task switching. J. Exp. Psychol. Hum. Percept. Perform. 2001, 27(4):763-797.
59. Sawaguchi T., Goldman-Rakic P.S. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J. Neurophysiol. 1994, 71(2):515-528.
60. Manual for the state-trait anxiety inventory (form Y) Consulting Psychologists Press, Inc.: Palo Alto.
61. Stelzel C., Basten U., Montag C., Reuter M., Fiebach C.J. Effects of dopamine-related gene-gene interactions on working memory component processes. Eur. J. Neurosci. 2009, 29(5):1056-1063. 10.1111/j.1460-9568.2009.06647.x.
62. Thompson J., Thomas N., Singleton A., Piggott M., Lloyd S., Perry E.K., et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997, 7(6):479-484.
63. Volkow N.D., Wang G., Fowler J.S., Logan J., Gerasimov M., Maynard L., et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J. Neurosci. Off. J. Soc. Neurosci. 2001, 21(2):RC121.
64. Wagenmakers E.J. A practical solution to the pervasive problems of p values. Psychon. Bull. Rev. 2007, 14(5):779-804.
65. Weible A.P., Rowland D.C., Pang R., Kentros C. Neural correlates of novel object and novel location recognition behavior in the mouse anterior cingulate cortex. J. Neurophysiol. 2009, 102(4):2055-2068. 10.1152/jn.00214.2009.
66. Williams G.V., Castner S.A. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience 2006, 139(1):263-276. 10.1016/j.neuroscience.2005.09.028.
67. Winterer G., Coppola R., Goldberg T.E., Egan M.F., Jones D.W., Sanchez C.E., et al. Prefrontal broadband noise, working memory, and genetic risk for schizophrenia. Am. J. Psychiatry 2004, 161(3):490-500.
68. Yehene E., Meiran N., Soroker N. Basal ganglia play a unique role in task switching within the frontal-subcortical circuits: evidence from patients with focal lesions. J. Cogn. Neurosci. 2008, 20(6):1079-1093. 10.1162/jocn.2008.20077.
69. Zhang Y., Bertolino A., Fazio L., Blasi G., Rampino A., Romano R., et al. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc. Natl Acad. Sci. USA 2007, 104(51):20552-20557. 10.1073/pnas.0707106104.
70. Zhang Y., Jiang B., Zhu J., Liu J.S. Bayesian models for detecting epistatic interactions from genetic data. Ann. Hum. Genet. 2011, 75(1):183-193.